PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsPreimplantation genetic diagnosis for cancer risk during IVF is feasible, study indicates

BioNews

Preimplantation genetic diagnosis for cancer risk during IVF is feasible, study indicates

Published 13 March 2013 posted in News and appears in BioNews 664

Author

Sarah Pritchard

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.

It is now scientifically feasible to use preimplantation genetic diagnosis (PGD) during IVF to screen embryos for genes associated with high cancer risk, scientists say...

It is now
scientifically feasible to use preimplantation genetic diagnosis (PGD) during
IVF to screen embryos for genes associated with high cancer risk, scientists
say.

European researchers presented the results of a major study - as yet the
largest in this area of research - at the European Society of Human
Reproduction and Embryology's annual meeting in Istanbul, Turkey. They conclude
that the technique can be used reliably so that men and women who carry cancer-causing mutations in their BRCA1 or BRCA2 genes do not pass them on to
their children. Female carriers of a mutation in either gene have a 60 to 80 percent
chance of developing breast cancer over their lifetimes, and a risk of 30 to 60
percent (BRCA1) or five to 20 percent (BRCA2) for ovarian cancer

The PGD procedure allows doctors to identify which embryos carry these genes,
and therefore only implant ones that do not, thereby removing the mutation from
the family tree.

The study looked at 145 cycles of IVF in 70 couples where one partner carried one
of the BRCA mutations. A total of 717 embryos were created for these couples
and grown for three days - when they would have comprised eight cells - at which
point one cell was extracted and tested for the presence of a BRCA mutation.

Overall, 43 percent of the embryos were affected, while 40 percent did not
carry the mutations and were considered viable. Using the unaffected embryos, the
couples achieved a 41 percent pregnancy rate, or 42 pregnancies in 40 women in
total.

'We now believe that this technique offers an established option for those
couples seeking to avoid the risk of inherited BRCA in their children', said
Professor William Verpoest, from the Vrije University in Brussels, who
presented the study.

Speaking to the BBC, Mr Stuart Lavery, director of IVF at Hammersmith
Hospital in London said that the study, published months earlier in the journal
Human Reproduction, was 'quite an important paper'. He said that knowing that removing
'12.5 percent of the whole genetic mass of the embryo' for testing did not
to affect the embryo's viability was 'hugely reassuring'.

In his presentation Professor Verpoest
recognised the debates on the ethics of using PGD to screen for BRCA mutations.
Cancers associated with the BRCA mutations occur late in life and therefore
options for treating them are constantly improving. 'Controversy will still
remain over the ethical acceptability of PGD for a susceptible, yet preventable
condition', he said.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
15 May 2017 • 1 minute read

Gene associated with treatment-resistant ovarian cancers identified

by Chris Baldacci

Scientists have discovered a gene called FGF1 which is highly active in aggressive and advanced ovarian cancers...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
16 December 2013 • 6 minutes read

Progress Educational Trust conference: Making the grade

by James Brooks

The third session of the Progress Educational Trust's annual conference 'The Best Possible Start in Life: The Robust and Responsive Embryo' boasted a redoubtable roll-call of eminent clinicians and researchers as speakers...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Reviews
14 October 2013 • 4 minutes read

Event review: Genetic Testing in Assisted Reproduction - Selecting, Not Perfecting?

by Dr Jamie Heather

We had almost made it through the speakers when it happened, just before the break. It was the last speaker who did it. It was Dr Joyce Harper who said what I'd been waiting for, and dropped the Gattaca bomb...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
30 January 2013 • 4 minutes read

Beyond the treatment of infertility

by Professor Mary Herbert

The advent of PGD extended the scope of IVF beyond the treatment of infertility. PGD is predominantly used to prevent transmission of genetic defects arising from mutations in nuclear DNA. However, it can also be used to reduce the risk of transmitting mutations in mitochondrial DNA (mtDNA), which cause a range of debilitating and life-threatening diseases...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
1 November 2012 • 2 minutes read

New genetic test may help to improve IVF success

by Dr Rosie Morley

Multiple genetic tests have been performed on a single embryo for almost the first time, according to US researchers. The researchers from John Hopkins School of Medicine say their technique for making copies of an embryo's DNA can improve IVF success rates...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
5 August 2011 • 2 minutes read

Changes to PGD regulation in Victoria, Australia

by Dr Malcolm Smith

The Australian state of Victoria was the first common law jurisdiction in the world to enact legislation to regulate assisted reproductive technologies (ARTs). Victoria's legislative framework has been updated a number of times and the most recent legislation (the Assisted Reproductive Treatment Act 2008 (Vic)) came into effect on 1 January 2010...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
8 July 2011 • 1 minute read

Germany allows PGD for life-threatening genetic defects

by Nishat Hyder

The German parliament has passed a new law allowing PGD in limited circumstances. Under the new law, couples undergoing IVF can use PGD to screen embryos only if the parents have a predisposition to a serious genetic illness...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Coffee and saturated fats not good for IVF success, studies say

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

15 August 2022 • 2 minutes read

Call to end ban on HIV-positive partner gamete 'donation'

15 August 2022 • 2 minutes read

Melanoma invades new tissues using nerve cell gene

15 August 2022 • 2 minutes read

Exceeding alcohol limits could damage DNA and accelerate ageing

15 August 2022 • 2 minutes read

Blood cell gene mutations affect mitochondria, increasing cardiovascular disease risk

15 August 2022 • 2 minutes read

Jumping gene helps immune system fight viruses

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856